Leerink Partnrs Decreases Earnings Estimates for CVS Health

CVS Health Co. (NYSE:CVS - Free Report) - Investment analysts at Leerink Partnrs cut their Q1 2025 earnings estimates for CVS Health in a research report issued on Saturday, October 19th. Leerink Partnrs analyst M. Cherny now expects that the pharmacy operator will post earnings per share of $1.49 for the quarter, down from their previous forecast of $1.59. The consensus estimate for CVS Health's current full-year earnings is $6.51 per share. Leerink Partnrs also issued estimates for CVS Health's Q2 2025 earnings at $1.82 EPS, Q3 2025 earnings at $1.86 EPS and Q4 2025 earnings at $1.80 EPS.

A number of other research firms have also issued reports on CVS. Truist Financial upped their target price on shares of CVS Health from $66.00 to $76.00 and gave the stock a "buy" rating in a report on Friday, October 11th. Evercore ISI increased their price objective on shares of CVS Health from $62.00 to $75.00 and gave the company an "outperform" rating in a report on Tuesday, October 8th. Cantor Fitzgerald restated a "neutral" rating and set a $62.00 target price on shares of CVS Health in a report on Tuesday, October 1st. Deutsche Bank Aktiengesellschaft cut their price target on CVS Health from $64.00 to $63.00 and set a "hold" rating for the company in a report on Friday, August 9th. Finally, TD Cowen upgraded CVS Health from a "hold" rating to a "buy" rating and upped their target price for the company from $59.00 to $85.00 in a report on Friday, October 4th. Nine analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $75.26.

CVS Health Price Performance

NYSE CVS traded down $1.32 during mid-day trading on Tuesday, hitting $56.85. The stock had a trading volume of 14,539,533 shares, compared to its average volume of 11,255,983. The firm's 50 day moving average is $59.87 and its 200 day moving average is $60.19. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.86 and a quick ratio of 0.66. The stock has a market capitalization of $71.37 billion, a price-to-earnings ratio of 9.99, a PEG ratio of 0.93 and a beta of 0.54. CVS Health has a twelve month low of $52.77 and a twelve month high of $83.25.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.73 by $0.10. The company had revenue of $91.23 billion for the quarter, compared to analysts' expectations of $91.41 billion. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. CVS Health's revenue was up 2.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.21 EPS.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 1st. Shareholders of record on Monday, October 21st will be given a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.68%. The ex-dividend date is Monday, October 21st. CVS Health's dividend payout ratio is presently 46.75%.

Institutional Investors Weigh In On CVS Health

Institutional investors have recently modified their holdings of the company. International Assets Investment Management LLC lifted its holdings in CVS Health by 8,947.4% during the 3rd quarter. International Assets Investment Management LLC now owns 1,145,849 shares of the pharmacy operator's stock worth $72,051,000 after buying an additional 1,133,184 shares during the last quarter. SOL Capital Management CO raised its position in shares of CVS Health by 14.6% during the 3rd quarter. SOL Capital Management CO now owns 71,142 shares of the pharmacy operator's stock worth $4,473,000 after acquiring an additional 9,075 shares in the last quarter. McAdam LLC acquired a new position in CVS Health in the third quarter valued at approximately $274,000. Searle & CO. increased its stake in CVS Health by 1.1% in the third quarter. Searle & CO. now owns 28,130 shares of the pharmacy operator's stock valued at $1,769,000 after purchasing an additional 300 shares during the last quarter. Finally, Commerzbank Aktiengesellschaft FI lifted its position in shares of CVS Health by 187.4% during the 3rd quarter. Commerzbank Aktiengesellschaft FI now owns 79,410 shares of the pharmacy operator's stock worth $4,994,000 after buying an additional 51,775 shares during the last quarter. 80.66% of the stock is owned by hedge funds and other institutional investors.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.